JY
IMNM icon

Jeff Yass’s Immunome IMNM Stock Holding History

Jeff Yass’s Portfolio IMNM Stock Details IMNM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.39M Sell
159,900
-2,500
-2% -$53.5K ﹤0.01% 5383
2026
Q1 		$3.55M Sell
162,400
-270,300
-62% -$6.02M ﹤0.01% 4911
2025
Q4 		$9.29M Buy
432,700
+236,900
+121% +$4.16M ﹤0.01% 3144
2025
Q3 		$2.29M Buy
195,800
+172,500
+740% +$1.72M ﹤0.01% 5487
2025
Q2 		$217K Buy
23,300
+2,400
+11% +$19.7K ﹤0.01% 11049
2025
Q1 		$141K Buy
20,900
+3,300
+19% +$31.7K ﹤0.01% 11280
2024
Q4 		$187K Buy
+17,600
New +$213K ﹤0.01% 10802
2024
Q3 		– Sell
-39,100
Closed -$473K – 12462
2024
Q2 		$473K Buy
39,100
+14,400
+58% +$225K ﹤0.01% 8395
2024
Q1 		$610K Sell
24,700
-20,700
-46% -$420K ﹤0.01% 8038
2023
Q4 		$486K Buy
45,400
+6,900
+18% +$57.4K ﹤0.01% 8731
2023
Q3 		$321K Buy
38,500
+27,900
+263% +$205K ﹤0.01% 9206
2023
Q2 		$83.8K Buy
+10,600
New +$58K ﹤0.01% 11073
2022
Q4 		– Sell
-24,300
Closed -$108K – 12998
2022
Q3 		$108K Buy
+24,300
New +$114K ﹤0.01% 11625
2022
Q1 		– Sell
-47,300
Closed -$613K – 13460
2021
Q4 		$613K Buy
47,300
+13,000
+38% +$232K ﹤0.01% 8613
2021
Q3 		$835K Buy
+34,300
New +$598K ﹤0.01% 8021

Other funds holding IMNM

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
California State Teachers Retirement System (CalSTRS)
California State Teachers Retirement System (CalSTRS) West Sacramento, California $782B AUM 28.39% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return

Jeff Yass's IMNM Position: Q2 2026 in Review

Jeff Yass reduced its Immunome (IMNM) stake by 46% in Q2 2026, selling an estimated $577K and leaving 32,007 shares worth $678K. The position accounts for ﹤0.01% of the portfolio, ranked #9183.

Jeff Yass first reported a position in IMNM in Q3 2021 and has held it in 19 quarters since. The position peaked at $9.27M in Q1 2025. 201 funds tracked by Wall St. Rank hold IMNM as of Q2 2026.

  • Jeff Yass held 32,007 shares of Immunome worth $678K as of Q2 2026.
  • Jeff Yass sold 26,978 Immunome shares in Q2 2026, an estimated $577K.
  • Immunome made up ﹤0.01% of Jeff Yass's portfolio in Q2 2026, its #9183 holding.
  • Jeff Yass first reported a position in Immunome in Q3 2021 and has held it in 19 quarters since.
  • Jeff Yass's Immunome position peaked at $9.27M in Q1 2025.
  • 201 funds tracked by Wall St. Rank held Immunome as of Q2 2026.

Based on Susquehanna International Group's 13F filing for Q2 2026, filed 14 Aug 2026.